Malnutrition prevalence, screening and outcome in hospitalised children in Europe: a prospective multicentre cohort study by Hecht, Christina Barbara
Aus der Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig-
Maximilians-Universität München 
Direktor: Prof. Dr. Dr. Christoph Klein 
 
 
 
 
Malnutrition  
 
Prevalence, screening and outcome in hospitalised 
children in Europe: a prospective multicentre cohort 
study 
 
 
 
 
Dissertation zum Erwerb des Doktorgrades der Humanbiologie an der Medizinischen 
Fakultät der Ludwig-Maximilians-Universität zu München 
 
 
 
 
vorgelegt von 
Christina Barbara Hecht 
aus München 
Jahr 
2019 
 
 
  
 
 
Mit Genehmigung der Medizinischen Fakultät  
der Universität München 
 
 
 
 
 
 
 
 
1. Berichterstatter:    
Prof. Dr. Dr. h.c. Prof. h.c Berthold Koletzko 
 
Mitberichterstatter: 
 Prof. Dr. Ursula Kuhnle-Krahl 
Prof. Dr. Rolf Holle 
Prof. Dr. Jochen Gensichen 
Prof. Dr. Konstantin Strauch 
 
Dekan: 
Prof. Dr. med. dent. Reinhard Hickel  
 
Tag der mündlichen Prüfung: 21.08.2019 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
__________________________________________________________________________ 
 
Die vorliegende Arbeit wurde nach § 4 a der Promotionsordnung für die Medizinische 
Fakultät der Ludwig-Maximilians-Universität München als kumulative Dissertation gestaltet. 
__________________________________________________________________________ 
 
  
Eidesstattliche Versicherung 
 
 
 
Hecht, Christina 
 
Name, Vorname 
 
 
 
Ich erkläre hiermit an Eides statt, 
dass ich die vorliegende Dissertation mit dem Thema 
 
Malnutrition 
 
Prevalence, screening and outcome in hospitalised children in Europe: a prospective 
multicentre cohort study 
 
selbständig verfasst, mich außer der angegebenen keiner weiteren Hilfsmittel bedient und 
alle Erkenntnisse, die aus dem Schrifttum ganz oder annähernd übernommen sind, als 
solche kenntlich gemacht und nach ihrer Herkunft unter Bezeichnung der Fundstelle einzeln 
nachgewiesen habe. 
Ich erkläre des Weiteren, dass die hier vorgelegte Dissertation nicht in gleicher oder in 
ähnlicher Form bei einer anderen Stelle zur Erlangung eines akademischen Grades 
eingereicht wurde. 
 
 
 
München, 29.11.2019    Christina Hecht 
Ort, Datum  
     
Unterschrift Doktorandin 
 
 
 
 
Table of content 
5 
 
 
Table of content 
 
1. List of abbreviations ....................................................................................................... 6 
2. List of publications .......................................................................................................... 7 
3. Introduction .................................................................................................................... 8 
4. Objectives and author’s contribution ..............................................................................20 
5. Abstract .........................................................................................................................22 
6. Zusammenfassung ........................................................................................................25 
7. Publication I ...................................................................................................................28 
8. Publication II ..................................................................................................................39 
9. References ....................................................................................................................75 
10. Acknowledgements .......................................................................................................84 
List of abbreviations 
6 
 
 
1. List of abbreviations 
 
BMI  Body mass index 
CDC  Centers for Disease Control and Prevention 
DRM  Disease-related malnutrition 
DXA  Dual-energy X-ray absorptiometry 
ESPEN European Society for Parenteral and Enteral Nutrition 
FTT  Failure to thrive 
HCG  Hellenic growth charts 
HFA  Height-for-age 
LOS  Length of hospital stay 
MAM  Moderate acute malnutrition 
MUAC  Mid-upper arm circumference 
NCHS  National Centre for Health Statistics 
NRS  Nutritional Risk Score 
NST  Nutritional screening tool 
PediSMART Pediatric Digital Scaled Malnutrition Risk Screening Tool 
PNRS  Simple Pediatric Nutritional Risk Score 
PNST  Pediatric Nutritional Screening Tool 
PYMS  Paediatric Yorkhill Malnutrition Score 
SAM  Severe acute malnutrition 
SDS  Standard deviation score 
SGNA  Subjective Global Nutritional Assessment 
STAMP Screening Tool for the Assessment of Malnutrition in Paediatrics 
STRONGKIDS Screening Tool for Risk of Impaired Nutritional Status and Growth 
TSFT  Triceps skin fold thickness 
UNICEF United Nations Children’s Fund 
WFH  Weight-for-height 
WHO  World Health Organisation 
 
 
List of publications 
 7
 
2. List of publications 
 
The present thesis comprises two published research articles: 
 
Publication I: Hecht C, Weber M, Grote V et al. Disease associated malnutrition correlates 
with length of hospital stay in children. Clinical Nutrition 2015;34(1):53-9. 
doi:10.1016/j.clnu.2014.01.003 
 
Publication II: Chourdakis M, Hecht C, Gerasimidis K et al. Malnutrition risk in hospitalized 
children: use of 3 screening tools in a large European population. Am J Clin Nutr. 2016 May; 
103(5):1301 – 10. Doi: 10.3945/ajcn.115.110700. Epub 2016 Apr. 2016 
 
 
 
Introduction 
 8
 
3. Introduction 
 
Disease-related malnutrition  
 
Disease-related malnutrition (DRM) is a highly prevalent condition in a large number of 
European hospitals and is associated with increased healthcare costs [1-4]. It affects 
individuals across various life stages including early infancy, childhood and adolescence [5]. 
DRM is found in 6 - 37% of hospitalised children, depending on the chosen criteria and 
reference values [6, 7]. Recently, Freijer et al. performed a cost-of-illness analysis showing 
that DRM in paediatric Dutch patients in non-academic hospitals is associated with an 
increase of 80 million euros in annual hospital costs [4]. Task forces around the world have 
gathered data and experience and have summarised evidence into guidelines [5, 8-11]. Over 
the last years mandatory screening for DRM in hospitalised children was introduced in 
several countries, including the Netherlands and France [12]. The overall goal of nutrition 
societies is to ensure that screening for DRM becomes an integral part of routine nutritional 
practice [11]. 
 
Malnutrition – Underweight 
 
The United Nations Children’s Fund (UNICEF) remarks that although the word ‘malnutrition’ 
is commonly used to refer to undernutrition, however, it technically also encompasses 
overnutrition [13]. Malnutrition can be due to insufficient macro- and micronutrient intakes 
due to environmental settings or excessive consumption of unhealthy products [14] or it can 
be a result of chronic disease [15]. Three months are recommended to be used as a cut-off 
to classify the duration of malnutrition as acute (< 3 months) or chronic (3 months and longer) 
[14]. The origin can include an underlying pathophysiology and/or inflammatory process [16]. 
Knowledge of the aetiology of malnutrition is highly important for specific treatment of the 
causes in addition to any symptoms [16]. However, DRM is often hard to detect and to 
diagnose at the onset since DRM is mostly subtle and indefinable [17]. Nutrition support must 
be appropriate to the pathology, pharmacology and management of the underlying cause 
[18]. Ethical and legal aspects have to be taken into account to determine if a nutrition 
intervention, therapy or counselling is necessary and supportive [17].  
In the past, undernutrition was associated with developing countries and overnutrition with 
developed countries [11]. Today many parts of the world experience a double burden of 
malnutrition [5, 19]. The definition of malnutrition is of interest for clinicians, coders and 
administrators for recordkeeping and billing purposes [20]. During the last three decades, the 
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clinical description and perspective of malnutrition has evolved [11]. A wide variety of 
definitions is used, depending on personal views, medical settings and disciplines [14, 21]. 
Lochs et al. introduced several clinical terms and definitions in the field of nutrition with 
regard to the ESPEN (European Society for Parenteral and Enteral Nutrition) Guidelines on 
Enteral Nutrition [22]. Malnutrition was defined as a state of nutrition in which a deficiency, 
excess or imbalance of energy, protein or other nutrients causes measurable adverse effects 
on body shape, size, composition, function or clinical outcomes [22]. ESPEN places the main 
focus on undernutrition, which was defined as a state resulting from lack of uptake or intake 
of nutrition leading to altered body composition (decreased fat free mass and body cell mass) 
leading to diminished physical and mental function and impaired clinical outcome from 
disease [23]. A few years ago, a new definition of paediatric malnutrition (undernutrition) was 
proposed by Mehta and colleagues: “… an imbalance between nutrient requirements and 
intake, resulting in cumulative deficits of energy, protein, or micronutrients that may 
negatively affect growth, development, and other relevant outcomes.” [14]. This definition 
takes into account that growth and development are of major concern in paediatrics. 
However, until summer 2017 no modifications were made to malnutrition diagnoses codes of 
the International Classification of Diseases, 10th Revision [12]. In a recent ESPEN 
consensus report one core concept of clinical nutrition was defined as 
malnutrition/undernutrition, which includes DRM with (e.g. cachexia) and without 
inflammation, and malnutrition/undernutrition without disease, e.g. hunger-related 
malnutrition [24]. Pathophysiology of the individuals is unfortunately not addressed in this 
categorisation [16]. 
 
In clinical trials investigating malnutrition, frequently used endpoints are morbidity, mortality, 
length of hospital stay (LOS) and cost efficacy [17]. Successful treatment of undernutrition 
should result in substantial clinical improvements for patients and considerable cost savings 
to health care systems and society [17]. Efficacy of treatments and benefits for the patients 
have to be characterised in well-designed trials. Weight gain and LOS could serve as 
outcome. 
 
In the context of this thesis, the focus is secondary (due to underlying disease) DRM in 
paediatrics, which is defined by underweight. Evaluation of undernutrition in neonates and 
micronutrient deficiencies are beyond the scope of this research. 
 
Malnutrition in paediatrics 
 
Malnutrition in infants, children and adolescents has even more serious consequences on 
the progression of the disease and long-term health than malnutrition in adults [25, 26]. Body 
stores are finite at young ages and several homeostatic and metabolic processes are still 
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limited [27]. The prompt identification and treatment of DRM in paediatrics is essential and 
yet more complex than for adults, as growth needs to be considered [19, 28]. In healthy 
young children, energy needs per kg body weight are about three times higher than in adults 
[27]. In diseased children, estimated average increases in energy reach 120 - 170%, and in 
critically ill paediatric patients, energy needs can reach up to 200% [27]. In addition, 
malnutrition and growth faltering during early childhood induce lasting damage at later stages 
of life, including cognitive abilities, body composition and body height [14, 29]. 
 
In scientific literature, documentation of the relationship between malnutrition in hospitalised 
children and outcome (e.g. length of hospital stay and complication rates) is limited [30, 31]. 
The evidence-base demonstrating to which extent malnourished paediatric patients will 
benefit from nutritional intervention is also inadequate [14]. According to previous studies, 
and depending on the method of assessment, DRM affects up to 24% of paediatric patients 
in Europe [6]. Potential reasons for this high prevalence include a lack of adequate 
diagnostic strategies and a lack of targeted nutritional care in paediatrics [21]. Equipment for 
anthropometric measurements is often inadequate, measurements are seldomly performed 
in a reliable way and collected data are frequently misinterpreted [5, 32]. A standardised 
approach to the recognition and diagnosis of paediatric malnutrition is lacking [11]. Available 
criteria are numerous, inconsistent and not based on firm evidence [11, 14, 21, 33].  
 
Diagnostic measures and criteria for malnutrition in children 
 
Anthropometry measures the anatomical changes associated with nutritional status. Weight 
is a very valuable tool in paediatric practice within growth assessment, particularly when 
combined with length or height in growth charts [23]. Mid-upper arm circumference (MUAC) 
is a useful surrogate for weight when weighing is impossible [11, 14, 34]. It can be combined 
with triceps skin fold thickness (TSFT) to derive useful correlates of muscle and fat mass [23]. 
Chronic malnutrition may, in addition to the anthropometric changes in acute malnutrition, be 
characterized by stunting (decreased height velocity) [14]. Currently, several different 
anthropometric indices for malnutrition in children are used, which do not correlate with each 
other and identify different groups and numbers of patients as malnourished [6, 35].  
Becker et al. recently published a consensus statement aiming to identify a basic set of 
indicators that can be used to diagnose and document undernutrition in the paediatric 
population aged 1 month to 18 years [11]. The choice of the cut-off values used to identify 
the status of (normal versus abnormal) and risk for (low versus high) malnutrition is of great 
influence for the results. Thus, the prevalence of malnutrition (based on underweight) varies 
according to the criteria applied [21]. Currently, the criteria used show great variation 
(summarised in Table 1).  
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Whereas Waterlow and Gomez defined three groups of malnutrition (mild, moderate and 
severe) other authors stayed with two or one group only. Waterlow proposed a classification 
for malnutrition based on a “rather arbitrary choice of groupings” [36] and chose percentiles 
of weight-for-height (WFH) based on the Gomez classification [37]. Gomez had shown the 
influence of the degree of malnutrition based on weight and the “Boston standard” (reference 
tables of weight-for-age derived from children in Boston from 1930 to 1956) on mortality. 
Both classifications, which were initially applied to infants and young children only, are 
nowadays often used in paediatric patients up to 18 years of age. Over the last several years, 
standard deviation scores (SDS) are increasingly used over percentile values [11, 28]. 
 
Table 1: Currently used criteria for malnutrition based on underweight (modified after 
Chourdakis [26]) 
Criteria 
Malnutrition grade 
Mild                             Moderate 
 
Severe 
 Acute Malnutrition 
   
Gomez 
[37] 75 - 90% WFAa  60 – 74% WFAa < 60% WFAa 
Waterlow  
[36] 80 - 90% WFHa 70 - ≤ 80% WFHa < 70% WFHa 
Tanner  
[38]  < 5th percentile WFH 
Olsen 
[33]   Weight and BMI for age < 5th percentile 
WHO 
[39]  
 
 < -2 to -3 SDS WFH  < -3 SDS WFH 
Ling (WHO) 
[40]  < -2 to -3 SDS BMI < -3 SDS BMI 
Chronic malnutrition (short stature as potential marker)  
WHO 
[39]  < -2 SDS HFA 
Olsen 
[33]  Length for age < 5th percentile 
aof the median of the gender specific reference values; BMI: Body mass index, HFA: Height-for-age, SDS: 
Standard Deviation Score, WFA: Weight-for-age, WFH: Weight-for-height, WHO: World Health Organisation 
 
Currently, the most commonly used criteria are the World Health Organisation (WHO) cut-
offs, which define moderate acute malnutrition (MAM) as WFH < -2 to -3 SDS, severe acute 
malnutrition (SAM) as WFH < -3 SDS and stunting as height-for-age (HFA) < -2 SDS, which 
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is a sign of chronic malnutrition [39, 41]. Olsen pointed out that in developed countries WFH 
references for children aged > 5 years of age are less available than age-specific body mass 
index (BMI) references, which is the case for e.g. WHO standards [11, 33]. It is difficult to find 
reliable reference data for WFH SDS for children older than 5 years. Therefore BMI < -2 SDS 
is often used as a simple proxy for defining malnutrition due to feasibility [40].  
 
Mei et al. compared BMI and WFH data of children aged 2 - 19 years who participated in the 
NHANES III survey (National Health and Nutrition Examination Survey, US population) [42]. 
They concluded that BMI and WFH had a similar predictive value for low body fat, based on 
TSFT (n = 11096) and percentage of body fat or total body fat measured by dual-energy X-
ray absorptiometry (DXA). The DXA data (n = 920, 3 - 19 years of age) were derived from 
pooled data sets of children in the United States, Italy and New Zealand. Olsen compared 
seven clinically-used criteria (including Waterlow and Gomez criteria) for failure to thrive 
(FTT) in a large Danish cohort aged 2 - 11 months and found poor agreement among them 
[33]. Of interest, less than half of the infants identified by the Waterlow criterion as 
malnourished had a weight < 5th percentile, but all had a BMI < 5th percentile. 
 
As stated above, the choice of the criterion and of the reference influences the assessed 
prevalence of and risk for malnutrition [21]. Fernandez et al. wrote that cut-off values might 
even require adapting to reference values in order to maintain diagnostic accuracy [34]. 
Reported and used references are, for example, the international WHO standards, the 
Centers for Disease Control and Prevention (CDC) references or national ones [6]. Silveira et 
al. compared the National Centre for Health Statistics (NCHS), CDC and WHO growth charts 
in Brazilian children aged 0 - 5 years [43]. Despite the documented strong agreement, they 
recommend WHO charts for the detection of malnourished children, due to their high 
sensitivity. However, the WHO growth standards differ from national references [44, 45]. 
They are based on anthropometric data collected from 1994 to 2003 in Brazil, Ghana, India, 
Norway, Oman and USA and a good choice for international, multi-centre settings. For 
national or single centre settings, national references could be the better and more 
representative choice depending on the date of data collection.  
Data presented in this thesis have been compared to the WHO growth standards [39] 
because data collection was performed in a multi-country setting. 
 
Nutritional risk screening 
 
The primary objective of screening is the early detection of a condition at a stage when 
treatment is less expensive, more effective, or both [46]. Global performance of nutritional 
screening on admission in all patients, using a validated nutritional screening tool (NST), is of 
high importance and should be standard of practice [47]. The screening results can give the 
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direction to applying specific nutrition therapy shortly after admission [12]. Therefore, it is 
necessary to increase the awareness of health care professionals for this topic and to 
provide clear strategies and concepts. Nutrition therapy should aim to prevent malnutrition 
rather than being used as a therapeutic intervention once DRM has already developed, and 
has negatively impacted the paediatric patients [48].  
The foundation of any nutritional care plan is the identification of patients at nutritional risk 
[49]. A good screening instrument, however, should not only be simple, rapid and easy to 
carry out by admitting staff. It should also meet content validity, predictive validity and 
reliability and should lead to appropriate and explicit action [50]. Patients found to be at 
nutritional risk should undergo a detailed assessment, including history, examination, 
bedside tests and relevant laboratory tests. Based on screening and assessment results, a 
nutrition management and monitoring plan should be developed. Nutrition support should be 
considered in patients thought to be malnourished or at risk of malnutrition. 
The ideal tool for screening and assessing malnutrition in paediatrics is still debated in the 
scientific literature [51]. The first tool to be found in paediatric literature is the Reilly 
Nutritional Risk Score (NRS) [52]. However, evidence to support the use of the NRS is 
insufficient [53]. Within the last decade, further paediatric malnutrition risk screening tools 
have been developed and validated [51, 54]. The earlier ones, including the Subjective 
Global Nutritional Assessment (SGNA) and the Simple Pediatric Nutritional Risk Score 
(PNRS) are more a detailed assessment, time-consuming and necessary data cannot be 
collected within one day [55-57]. Thus, they are too complicated for use in daily clinical 
practice [21]. Some other tools address specific patient groups with specific nutritional needs 
such as for example a risk-based classification system for individuals with cystic fibrosis [58] 
or cancer [59]. Simpler tools have been proposed recently and are currently used, including 
the Paediatric Yorkhill Malnutrition Score (PYMS) [60-62], the Screening Tool for the 
Assessment of Malnutrition in Paediatrics (STAMP) [63, 64] and the Screening Tool for Risk 
Of Impaired Nutritional Status and Growth (STRONGKIDS) [31]. Those three tools are quickly 
filled out and can therefore be applied within one day after admission. A validation study in 
Belgium reported that the actual time needed for the completion of STRONGKIDS was 3 
minutes [46]. PYMS, STAMP and STRONGKIDS have been developed and applied in different 
hospital settings. Performance of the tools strongly depends on the growth charts and SDS 
applied. For example, it makes a great difference whether WHO-CDC vs. UK-WHO charts 
and WFH vs. BMI SDS are used when applying the PYMS tool [65]. The most recently 
developed tools are the Pediatric Digital Scaled Malnutrition Risk Screening Tool 
(PediSMART) [66] and the Pediatric Nutritional Screening Tool (PNST) [67]. 
 
Testing the clinical performance of a NST against an appropriate benchmark is important. 
Van Bokhorst-de van der Schueren and colleagues performed a systematic review of 
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screening tools for the hospital setting in adults and the elderly addressing the question 
“Does one size fit all?”[68]. They came to the conclusion that no single screening or 
assessment tool is suitable for satisfactory nutrition screening as well as predicting poor 
nutrition related outcome. Two recent reviews of paediatric NST concluded that all compared 
tools present with advantages and disadvantages [53, 69]. So far there is no adequate 
evidence to choose one NST over another for the general paediatric population [70]. 
 
ESPEN Research network grant project 
 
In 2009 Prof. Dr. med. Berthold Koletzko and colleagues drafted the basic concept for the 
project “Malnutrition and Outcome in Hospitalised Children in Europe” and successfully 
acquired the ESPEN Research network grant. All network partners had already participated 
in smaller studies on nutrition and nutritional assessment or in large European multi-centre 
studies. They were experienced in the field of paediatric clinical malnutrition such as 
detection and treatment in routine daily practice. The aim of the project was to characterize 
the prevalence of DRM on admission in hospitalised children across Europe. In addition, the 
effects of malnutrition in paediatric patients on relevant outcomes, such as LOS (primary 
outcome) and days with infectious complications (fever, antibiotic use), vomiting and 
diarrhoea should be assessed. A further goal was to compare feasibility, sensitivity and 
specificity of previously proposed paediatric screening tools and to characterize the 
prevalence of patients at risk for malnutrition based on the applied tools. To our knowledge, 
this was the first large-scale, European study on paediatric DRM. It was a cross sectional 
study with longitudinal elements (duration of hospital stay; days with infection). In contrast to 
adult medicine, this field of paediatric research had advanced very little due to lack of funding. 
Few data were available in European patient populations and the association between DRM 
and outcome has only been studied in scattered areas [25]. Published studies have used a 
wide variety of measures and criteria, and therefore the opportunity for meta-analysis is 
limited. The data and outcome of the ESPEN project with its large European cohort aimed at 
adding strength and evidence for nutrition interventions in paediatrics [71].  
 
DRM in hospitalised children: from scientific evidence to hospital practice 
 
The extensive ESPEN cohort study contributed valuable scientific evidence in the field of 
paediatric DRM. The results obtained reinforce the need of having paediatric nutrition teams 
and help accelerating the process of including screening as part of hospital quality of care 
criteria (personal communication with Prof. Frederic Gottrand (France) and Prof. Raanan 
Shamir (Israel) August 2017). The published data was used as evidence to support future 
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grants and to initiate further international research within the European paediatric population 
including the United Kingdom, Israel, France, Croatia and The Netherlands. The publication 
“Disease associated malnutrition correlates with length of hospital stay in children” is one of 
the most highly cited papers published in Clinical Nutrition in the year of publication (personal 
communication with Prof. Dileep Lobo, Chair Scientific Committee ESPEN 2017). Obviously, 
the interest in paediatric DRM in is growing. 
 
A tool with good diagnostic validity identifies the majority of patients you want to treat 
(sensitivity). Equally important is the good positive predictive value, which strongly depends 
on the specificity (i.e. 1- false positive rate). As already discussed, currently, there is no 
reference method for nutritional risk to compare to. BMI SDS was chosen as the best 
standard for undernutrition in our European setting.  
 
Sensitivity (proportion of patients with BMI < -2 SDS that have been categorised in the high-
risk group) was highest for PYMS (91%), followed by STAMP (77%) and lowest for 
STRONGKIDS (45%). Consequently, false negative rate (number of patients with BMI < -2 
SDS that have not been categorised in the high-risk group) was highest for STRONGKIDS 
(55%) and lowest for PYMS (9%). Positive predictive value (number of high risk patients with 
BMI < -2 SDS) was comparable low for all three NST (PYMS 22%, STAMP 19%, 
STRONGKIDS 23%). PYMS and STAMP both use anthropometric values (BMI, weight and 
height centiles) as components of the risk score. As there appear to be unavoidable 
statistical issues relating these two NST to BMI, associations with MUAC as well as with 
TSFT were explored additionally. MUAC and TSFT served as surrogate markers of 
undernutrition, which unlike BMI, are not contained in PYMS and STAMP. None of the NST 
was both sensitive and reasonably specific for identifying anthropometric depletion. 
 
HFA is an indicator of duration on undernutrition (chronicity). In terms of patients with HFA 
< -2 SDS positive predictive value was highest for STRONGKIDS (STRONGKIDS 19%, STAMP 
14%, PYMS 8%). False negative rate was nearly equally high for PYMS (74%) and 
STRONGKIDS (73%). Consequently, sensitivity was highest for STAMP (STAMP 42%, 
STRONGKIDS 27%, PYMS 26%). HFA sensitivity is low, because height is affected after a 
variable time of poor weight gain. In acute malnutrition (accompanying acute disease or 
decompensation of chronic illness) WFA is more sensitive, even if it might over-diagnose 
undernutrition. Because of this overdiagnosis, WFH or BMI are better indexes than HFA for 
the purpose of this study. The higher prevalence of stunting secondary to genetic, syndromic 
or neurologic disease is another important aspect that is relevant to tertiary hospitals in 
developed countries. It is evident that 58-74% of children with stunting have an adequate 
WFH stature and thus mistakenly do not belong to “high risk” category. However, the 
purpose of screening is to categorise inpatients according to the degree of likelihood of 
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suffering or being at risk of malnutrition rather than offering confirmatory diagnosis which 
should follow on and be carried out by the dietetic/medical team. 
 
A screening tool has to be as sensitive as possible. However, the resources and the capacity 
of the health system to cope with the implications of confirmatory diagnosis required for large 
number of test positive children must be taken into account. In situations where there is a low 
prevalence of undernutrition and limited number of false positives, this would not be a 
problem. Identification and selection of a valid tool should be the starting block in the clinical 
implementation of routine screening for malnutrition in a hospital. 
 
Our European data are in line with a recently published study among hospitalised children in 
the United States [72]. The US study showed paediatric DRM to be associated with longer 
LOS, lower quality of life, higher infection rates and an increased risk for complications [12]. 
Moreover, the reported prevalence of undernutrition found in our study corresponds with 
other European data, which indicate that roughly one in every ten hospitalised children 
suffers from undernutrition [73, 74]. Our findings also agree with the conclusions of the three 
reviews on NST mentioned before [53, 68, 69]. One NST which is applicable to 
heterogenous settings (e.g. residential, ambulatory/outpatient, acute care) in different 
paediatric hospitals all over Europe might not be achievable. Another recent systematic 
review provides a well-structured overview of the search for a consensus on paediatric NST 
in various disease-specific settings [51]. The authors conclude that further research should 
focus on performing large multi-centre studies comparing the currently existing tools rather 
than creating new tools. Creation of new NST seems needless and will most likely not lead to 
new insights [68]. Further studies comparing various existing NST within one patient 
population might be more constructive. A guide on how to assess clinical performance of a 
NST was published several years ago [60]. Milani et al. showed that acquisition of 
anthropometric measurements and assessment of growth in paediatric inpatients by nursing 
staff can be improved with the introduction of a screening tool [75].  
 
In a publication on the accuracy of NST in assessing the risk of undernutrition in paediatrics 
the authors underlined that the choice of the cut-off values will strongly influence sensitivity 
and specificity of the NST [53]. According to a recent review, WHO growth standards have a 
wide range of application, can be used for growth assessment of the majority of hospitalised 
infants and are used in over 50% of all countries worldwide [43, 76]. This is of special interest 
for the conduction of clinical projects with a multi-centre multi-country setting.  
 
In the last decade, paediatric malnutrition gained increased interest within nutritional 
societies and experts worldwide [6]. The French Paediatric Society recommends to assess 
each child with a BMI < -2 SDS for further signs of clinical malnutrition [77]. It is generally 
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agreed that identification and treatment of malnutrition should be a core competency for 
paediatricians and related health care professionals [9, 47].  
 
An Italian study described associations between NST score and serum albumin [78]. In 
Romania good agreement between WHO malnutrition classification and STRONGKIDS was 
found when adding low serum protein level to the tool [7]. However, it has to be ensured that 
the NST score is rapid and should not be delayed due to pending biochemical parameters. 
One step to enforce the evidence of future studies on DRM could be the use of BMI < -2 SDS 
as criterion and the WHO standard as reference. A harmonised approach would lead to 
comparable results and therewith strengthen the power of the findings.  
 
Additionally, in future research projects, it is important to focus in parallel on the subsequent 
step: how to translate the gained evidence best into clinical practice. A lot of field work needs 
to be done in the years to come as malnutrition is still often unrecognised and 
underestimated from the health-care staff [74]. Health-care staff members still tend to 
perceive DRM as an outcome rather than a medical condition [5]. One interesting approach 
was performed by Beer et al. [79]. Based on current developments in literature, they 
implemented a malnutrition identification program within a large tertiary care children’s 
hospital and assessed 522 admitted children. The program comprised a tool for dieticians 
that guided them on how to put all applied criteria into practice. Evaluation of the program 
showed that awareness and diagnosis of malnutrition increased strongly within one year after 
implementation. This result underlines that clinical teams need to be trained to monitor, 
record and interpret the nutritional status on a regular, systematic basis. Also Gerasimidis et 
al. published several years ago that good training of the staff during implementation period of 
a NST enhances compliance [60] as well as the collection of the impression of the end users 
(nurses, dieticians etc.) [62]. The end users need to understand the merit of nutritional 
screening [70] and to be convinced that it is worth applying NST. 
 
As we are still looking for the holy grail in the field of NST, best practice is to test various 
tools at various hospitals and settings and decide what NST is best in each respective 
environment. Nutritional screening and intervention in primary care settings might decrease 
the need for a costlier hospitalisation [80]. In a small Israeli study population STAMP was 
validated for ambulatory use in paediatrics [81]. The authors concluded, that the use of the 
NST helped to identify children in need of nutritional intervention and raised clinician’s 
awareness to nutritional status in general. Cheirakaki et al. applied PYMS and STAMP, that 
were completed based either on the WHO criteria for underweight or on the Hellenic growth 
charts (HCG) [82]. For their setting, two hospitals in Athens, PYMS combined with HCG 
performed best. Also Lestari et al., who conducted a study in Indonesia, were in favour of 
PYMS [83]. In contrary, two Spanish studies found STAMP to be the tool of choice [84, 85]. 
Introduction 
 18 
Other studies in Belgium, Italy and Romania used and validated the STRONGKIDS Tool [7, 46, 
78]. Also, in a study in New Zealand STRONGKIDS performed best [86].  
 
Next to the transfer from evidence to practice challenges and pitfalls in practice have to be 
evaluated. Over the last several years, nutritional screening has been increasingly performed 
in paediatric inpatients, but a large number of malnourished children still remain undiagnosed 
and untreated. Table 2 presents barriers to nutrition screening on different levels.  
 
Table 2: Challenges for the implementation of nutritional screening into routine 
practice (modified after Agarwal [5]) 
Management level 
Lack of clearly defined responsibility 
Lack of sufficient personnel capacity 
Lack of awareness, low priority 
Seldom mandatory and/or supported 
Health-care personnel level 
Lack of awareness and training 
Inadequate  
• time (due to competing priorities) 
• instruments (weighing scales, height measurements) 
• training and education (regarding the use of the tools) 
Perception that the tool is “too complex” or “too complicated” to use 
Confusion between screening and assessment 
Preference for other parameters to determine nutritional status such as biochemical markers  
Prioritising medical treatment over nutritional support 
Patient and parent level 
Prioritising medical treatment over nutritional support 
Cultural and/ or educational differences 
 
A large, nationwide survey in Belgian secondary-level hospitals showed that lack of training 
and awareness among staff is one general reason [70]. In paediatrics, a deficit of validated 
protocols for screening, assessment and treatment are still an issue, as well as the enduring 
use of inconsistent criteria for malnutrition. Despite increasing awareness of the importance 
of nutritional support during the last two decades, organised nutritional screening, 
assessment und management is still not fully established in clinical practice [70]. 
 
In conclusion, effective and early detection and treatment of DRM in paediatric patients 
should be key priorities. They should become the mutual interest of doctors, hospital 
administration and health authorities represented in collaboration with and appreciation for 
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nutritional teams. Improved organisation of nutritional screening, assessment and therapy 
will most likely have both clinical and economics benefits in the hospital service. Efficacy of 
nutritional therapies has to be explored in future studies. The newly formed ESPEN Special 
Interest Group in Paediatric Clinical Nutrition [87] might be the leading task force to achieve 
this goal in the subsequent years.  
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4. Objectives and author’s contribution 
 
The present thesis comprises two published research articles which are both derived from 
data collected within the framework of the ESPEN Research network grant project. The 
overall contribution of the author to the project and the two articles is described as follows: 
 
• ESPEN Network Grant project - project management and study coordination: 
Preparation of the study protocol, application to the local ethical committee, 
registration at ClinicalTrials.gov, preparation of the agreements governing the joint 
conduct of the clinical trial between the sponsor and the trial sites in collaboration with 
the legal department, budget responsibility, planning and conduction of the training 
workshop in Munich, development and preparation of the case report forms and the 
standard operating procedures and organisation of study meetings  
 
• Data collection, data management and data analysis: 
Data collection at the coordinating centre in Munich, coordination of the global data 
monitoring (collection and source data) and global data review for data quality check, 
major part of the data entry (copies of the CRFs of all centres were sent to Munich for 
data entry), major part of data management and statistical analysis (with support of 
Weber M and Grote V) 
 
The key objectives of this work are to: 
• Characterise the prevalence of paediatric malnutrition at hospital admission in Europe 
• Determine the effect of paediatric malnutrition on selected outcomes 
• Check proposed paediatric screening tools against each other 
• Compare the screening tools and their predictive value on outcomes 
 
In summary, the results of the present publications indicate that: 
• the overall prevalence of paediatric malnutrition at hospital admission was 7%, with a 
higher prevalence in infants (10.8%) and toddlers aged 1 - 2 years (8.3%). 
• paediatric malnutrition is associated with selected outcomes: longer LOS, lower 
quality of life and increased frequency of vomiting and diarrhoea. 
• the use of applied paediatric screening tools (PYMS, STAMP, STRONGKIDS) cannot 
be recommended for assessing nutritional risk in routine clinical practice due to small 
agreement between the tools. 
• all three tools showed a predictive value on LOS and on body composition. 
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Publication I: Hecht C, Weber M, Grote V et al. Disease associated malnutrition correlates 
with length of hospital stay in children. Clinical nutrition 2015;34(1):53-9. 
doi:10.1016/j.clnu.2014.01.003 
 
Contribution of Hecht C: 
Drafting and preparation of the manuscript, coordination of co-authors’ intra-group reviews 
and communication, conclusion and discussion, revision of the manuscripts and integration 
of reviewers’ comments towards publication. 
 
In a large European paediatric cohort of 2567 inpatients from 14 hospitals in 12 countries a 
BMI < -2 SDS was present in 7% of the study participants at hospital admission. BMI and 
WFH < -2 SDS had a good level of agreement (97%), but BMI showed a higher prevalence 
of severely malnourished children (2.1% vs.1.5%). Low BMI (-2 to -3 SDS, < -3 SDS) was 
correlated with a longer LOS (1.3 days and 1.6 days; respectively), lower quality of life (total 
score ≥4 in 15.1% malnourished vs. 6.4% well-nourished children, p < 0.001) and increased 
frequency of vomiting (26% vs.14%; p < 0.001) and diarrhoea (22% vs. 12%, p < 0.001). 
 
Publication II: Chourdakis M, Hecht C, Gerasimidis K et al. Malnutrition risk in hospitalized 
children: use of 3 screening tools in a large European population. Am J Clin Nutr. 2016 May; 
103(5):1301 – 10. Doi: 10.3945/ajcn.115.110700. Epub 2016 Apr. 2016 
 
Contribution of Hecht C: 
First drafting and preparation of the manuscript, coordination of co-authors input, discussions 
within the writing group, answering of reviewers’ comments including additional statistical 
analysis. 
 
The identification and classification of risk of malnutrition varied between the three applied 
tools PYMS, STAMP and STRONGKIDS, with an agreement of only 41%. A positive 
association was found between high malnutrition risk (PYMS: 25%; STAMP: 23%; 
STRONGKIDS: 10%) and LOS (1.4, 1.4 and 1.8 days longer, respectively) and a reverse 
association was found between body composition (MUAC and TSFT) and nutritional risk 
status. 
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5. Abstract 
 
Background 
Disease-related malnutrition is often not directly identifiable and it is seriously 
underestimated in affluent societies. In European, hospitalised children, a prevalence of 6 –
 30% is reported. This wide range is due to the lack of harmonised diagnostic criteria. 
Various anthropometric indices classify different patient groups as malnourished. In 
industrialized countries, an association between malnutrition and important clinical variables 
e.g. length of hospital stay (LOS) in paediatric patients was reported for few studies with 
small cohorts only. Similarly, there is no clear evidence for the use of nutritional screening 
tools (NST) to define the risk for malnutrition in paediatrics. 
 
Objectives 
Within the framework of a large European cohort study, we performed selected 
anthropometry in hospitalised children and evaluated the following NST which were 
previously reported in the literature: “Paediatric Yorkhill Malnutrition Score” (PYMS), 
“Screening Tool for the Assessment of Malnutrition in Paediatrics” (STAMP) and “Screening 
Tool for Risk of Impaired Nutritional Status and Growth” (STRONGKIDS). We aimed to indicate 
the prevalence of underweight and stunting and possible associations with relevant 
outcomes (LOS and complications rates). In addition, we evaluated how the three NST 
compared with and were related to anthropometric measures and clinical variables. 
 
Methods 
Between February 2010 and July 2011, a total of 2567 hospitalised patients aged one month 
to 18 years were included in a prospective multi-centre nutrition study at 14 hospitals across 
12 European countries. The three NST were applied during a structured interview within 24 
hours after admission and standardised anthropometric measurements (weight, standing 
height or supine length, mid-upper arm circumference (MUAC) and triceps skin fold thickness 
(TSFT)) were performed. Patients were classified into different nutritional risk groups based 
on calculated NST scores. Body mass index (BMI), weight-for-height (WFH) and height-for-
age (HFA) were defined, translated into standard deviation scores (SDS, WHO reference) 
and grouped according to cut-offs. Tool based nutritional risk groups and SDS based 
nutritional status groups were compared with and were related to LOS (primary outcome), 
MUAC, TSFT, frequency of gastrointestinal complications (vomiting and diarrhoea) and 
infection rates (fever and antibiotic use), weight change during stay and quality of life (QOL). 
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Results 
Median age of all study participants was 4.7 years, 45% were female. During hospital stay 
(median 4.0 days) 12.3% of the patients got nutritional support. We found a BMI < -2 SDS in 
7% of study participants at hospital admission, including 2% of children with severe 
malnutrition (BMI < -3 SDS). Prevalence was higher the younger the children were (toddlers 
8.3% and infants 10.8%). Underweight (BMI < -2 SDS) and/or stunting (HFA < -2 SDS) was 
present in 13.4% of examined patients. QOL was lower in patients with low BMI and 
diarrhoea and vomiting was more frequent (22% vs. 12% and 26% vs. 14%; p < 0.001, both). 
LOS was longer in moderate (BMI -2 to -3 SDS) and severe (BMI < -3 SDS) malnourished 
children (1.3 days longer CI 95: 1.01, 1.55; p = 0.04 and 1.6 days CI 95: 1.27, 2.10; 
p < 0.001). For PYMS data from 86% of the children was available for analysis, for STAMP 
and STRONGKIDS it were 84% and 81%, respectively. The results of risk classification had 
only an overall agreement of 41% between the three NST. Patients categorised as high risk 
(PYMS: 25%; STAMP: 23%; STRONGKIDS: 10%) showed a longer LOS than patients at low 
risk (PYMS and STAMP: 1.4 days longer; STRONGKIDS: 1.8 days; p < 0.001). Thereby, a BMI 
< -2 SDS was found in 22% of the PYMS high risk patients and a HFA < -2 SDS in 8%; for 
STAMP and STRONGKIDS high risk patients results were 19% and 14% or rather 23% and 
19%, respectively. False negative rate (proportion of patients with BMI < -2 SDS that have 
not been categorised in the high risk group) was highest for STRONGKIDS (55%), followed by 
STAMP (23%) and lowest for PYMS (9%). 
 
Conclusion 
In this heterogeneous group (age, underlying diagnosis) of well-nourished and malnourished 
paediatric hospital patients, we found a correlation between nutritional status and clinical 
outcome, namely higher complication rates, considerably reduced QOL and longer LOS. The 
observational nature of the present study cannot establish causality. However, the data might 
be important evidence to underline the adverse effect of malnutrition on clinical outcomes in 
European paediatric patients. None of the three tested NST is of exclusive superiority of the 
others. Results varied between the tools and a remarkable number of children with 
subnormal anthropometric measures were not identified by all three NST. Based on the 
collected data no choice for recommendation could be made. The choice which tool should 
be used depends on the clinical setting, the hospital population and the country-specific 
regulations. It is important to develop a system, that suits the specific needs and 
circumstances. 
The demonstration of a correlation between the degree of risk for DRM and relevant 
outcomes (LOS) will hopefully lead to wide implementations of evidence-based nutritional 
interventions in paediatric patients. Thereby, collaboration with and appreciation for 
Abstract 
 24 
nutritional teams is of great importance. Efficacy of nutritional interventions has yet to be 
demonstrated in future studies. 
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6. Zusammenfassung 
 
Hintergrund 
Krankheitsbedingte Mangelernährung ist oft nicht unmittelbar zu erkennen und wird in 
unserer Überflussgesellschaft erheblich unterschätzt. Bei hospitalisierten Kindern in Europa 
wurde eine Häufigkeit von 6 - 30% berichtet. Diese große Spannweite beruht vor allem auf 
dem Fehlen einheitlicher diagnostischer Kriterien für Mangelernährung. Verschiedene 
anthropometrische Indizes definieren unterschiedliche Patientengruppen als mangelernährt. 
Pädiatrische Daten zum Zusammenhang zwischen Mangelernährung und wichtigen 
klinischen Zielgrößen z.B. Länge des Krankenhausaufenthalts („length of stay“, LOS) wurden 
bislang für Industrieländer nur in wenigen Studien mit kleinen Fallzahlen beschrieben. 
Ebenso gibt es in der Pädiatrie keine klare Datenlage zum Einsatz von Screening-
Werkzeugen („nutritional screening tools“, NST) für die Risikoabschätzung der 
Mangelernährung. 
 
Ziele 
Im Rahmen einer großen, europaweiten Kohortenstudie wurden bei hospitalisierten Kindern 
definierte anthropometrische Messungen durchgeführt und folgende in der Literatur 
beschriebene NST evaluiert: „Paediatric Yorkhill Malnutrition Score“ (PYMS), „Screening 
Tool for the Assessment of Malnutrition in Paediatrics“ (STAMP) und „Screening Tool for 
Risk of Impaired Nutritional Status and Growth“ (STRONGKIDS). Es galt die Häufigkeit von 
krankheitsbedingtem Untergewicht und Kleinwuchs, sowie mögliche Auswirkungen dieser 
auf relevanten Endpunkte (LOS, Komplikationsraten), zu erfassen. Zudem wurden die drei 
NST untereinander bezüglich der Einordnung der Patienten in die verschiedenen 
Ernährungsrisiko-Gruppen verglichen und die Ergebnisse mit anthropometrischen 
Messungen und klinischen Variablen in Beziehung gesetzt. 
 
Methoden 
Zwischen Februar 2010 und Juli 2011 wurden 2567 stationäre Patienten im Alter zwischen 1 
Monat und 18 Jahren aus 14 Kliniken von 12 europäischen Ländern in die prospektive 
multizentrische Studie aufgenommen. Die drei NST kamen während eines 
leitfadengestützten Interviews innerhalb von 24 h nach Krankenhausaufnahme zum Einsatz 
und es wurden standardisierte anthropometrische Messungen (Gewicht, Größe/Länge, 
Oberarmumfang (OAU) und Trizeps-Hautfalte (THF)) durchgeführt. Basierend auf den NST 
Daten wurden Punkte berechnet und die Patienten anhand dieser in Risikogruppen eingeteilt. 
Zudem wurden Körper-Masse-Index (BMI), Gewicht-zu-Größe-Index und Größe-zu-Alter-
Index gebildet, in „standard deviation score“ (SDS, WHO Child Growth Standards) übersetzt 
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und kategorisiert. NST basierte Ernährungsrisiko-Gruppen und SDS basierte 
Ernährungsstatus-Gruppen wurden miteinander verglichen. LOS (primärer Endpunkt), OAU, 
THF, Häufigkeit von gastrointestinalen Komplikationen (Erbrechen und Durchfall), 
Infektionsraten (Fieber und Antibiotikagabe), Gewichtsveränderung während des 
Klinikaufenthalts und Lebensqualität wurden mit den Gruppen in Beziehung gesetzt.  
  
Ergebnisse 
Das Alter der Studienteilnehmer betrug im Median 4,7 Jahre, 45% waren weiblich. Während 
des Krankenhausaufenthaltes (Median 4,0 Tage) erhielten 12,3% der Patienten eine 
ergänzende Ernährung. Bei Krankenhausaufnahme wiesen 7% der Studienteilnehmer einen 
niedrigen BMI (< -2 SDS) und 2% der Kinder ein sehr starkes Untergewicht (BMI < -3 SDS) 
auf. Die Prävalenz von Untergewicht war umso höher, je jünger die Kinder waren (1-2 jährige 
Kleinkinder 8,3% und Säuglinge 10,8%). Untergewicht (BMI < -2 SDS) und/oder Kleinwuchs 
(Körperlänge < -2 SDS) lagen bei 13,4% der untersuchten Patienten vor. Die Lebensqualität 
war bei Patienten mit vermindertem BMI geringer, wobei Erbrechen und Durchfall in dieser 
Patientengruppe vermehrt auftraten (22% vs. 12% und 26% vs. 14%; jeweils p < 0.001). Der 
Klinikaufenthalt war bei moderat (BMI -2 bis -3 SDS) und schwer (BMI < -3 SDS) 
mangelernährten Kindern im Vergleich zu den normal ernährten Kindern verlängert (1,3 
Tage länger CI 95: 1,01 - 1,55; p = 0,04 und 1,6 Tage länger CI 95: 1,27 – 1,10; p < 0,001). 
Für PYMS waren Daten von 86% der Kinder zur Auswertung verfügbar, für STAMP und 
STRONGKIDS waren es jeweils 84% und 81%. Die Ergebnisse zur Klassifizierung des 
Mangelernährungsrisikos zeigten beim Vergleich der drei NST lediglich eine 
Übereinstimmung von insgesamt 41%. Patienten, die sich in den Hochrisikogruppen 
befanden (PYMS: 25%, STAMP: 23%, STRONGKIDS: 10%) waren gegenüber solchen mit 
einem geringen Risiko durch einen längeren LOS gekennzeichnet (PYMS und STAMP 
jeweils 1,4 Tage länger; STRONGKIDS: 1,8 Tage länger; p < 0,001). Dabei hatten von den 
mittels PYMS identifizierten Hochrisiko-Patienten 22% einen BMI < -2 SDS und 8% einen 
niedrigen Größe-zu-Alter SDS (< -2); im Fall des STAMP und STRONGKIDS waren es jeweils 
19% und 14% bzw. 23% und 19%. Die falsch-negativ Rate (Anteil der Patienten mit einem 
BMI < -2 SDS, die nicht der Hochrisikogruppe zugeordnet wurden) war bei STRONGKIDS 
(55%) am höchsten, gefolgt von STAMP (23%) und am niedrigsten für PYMS (9%). 
 
Schlussfolgerungen 
In dieser heterogenen Gruppe (Alter und zugrundeliegende Diagnose) von normal- und 
mangelernährten stationären pädiatrischen Patienten konnten wir eine Korrelation zwischen 
Ernährungsstatus und klinischen Zielgrößen zeigen (gehäufte Komplikationen, deutlich 
eingeschränkte Lebensqualität und verlängerte Verweildauer). Aufgrund des beobachtenden 
Designs der Studie kann keine Kausalität herbeigeführt werden. Die Daten können jedoch 
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eine wichtige Evidenz darstellen, welche die negative Auswirkung von Mangelernährung auf 
klinische Zielgrößen bei pädiatrischen Patienten in Europa unterstreicht. Keiner der drei 
evaluierten NST ist von herausragender Überlegenheit. Die Ergebnisse variierten zwischen 
den NST und eine erhebliche Anzahl an Kindern mit subnormalen anthropometrischen 
Messungen wurde von allen drei NST nicht erfasst. Basierend auf den erhobenen Daten 
kann keine Empfehlung für die Anwendung eines NST ausgesprochen werden. Die Wahl des 
richtigen NST hängt vom klinischen Bereich, den Patientengruppen und den 
landspezifischen Vorschriften ab. Es ist wichtig einen Leitfaden zu generieren, der den 
speziellen Bedürfnissen und Umständen entspricht. 
Der Nachweis der Korrelation zwischen dem Grad des Risikos für Mangelernährung und 
relevanten Zielgrößen (LOS) sollte zukünftig zu umfassendem Einsatz evidenzbasierter 
Ernährungsintervention bei pädiatrischen Patienten führen. Dabei spielt die Zusammenarbeit 
mit und steigende Bedeutung von Ernährungsteams eine wichtige Rolle. Die Wirksamkeit der 
Ernährungsintervention muss in zukünftigen Studien gezeigt werden. 
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This is a pre-copyedited, author-produced version of an article accepted for publication in the 
American Journal of Clinical Nutrition following peer review. The version of record Michael 
Chourdakis, Christina Hecht, Konstantinos Gerasimidis et al. Malnutrition risk in hospitalized children: 
use of 3 screening tools in a large European population. The American Journal of Clinical Nutrition 
(2016) 103 (5): 1301-1310 is available online at: doi: 10.3945/ajcn.115.110700 
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